Abu Dhabi Stem Cell Centre (ADSCC) has now treated more than 2,000 patients suffering from COVID-19, leading to much faster recovery time for those infected with the disease.
ADSCC said of those patients who have received the stem cell treatment, 1,200 have fully recovered from the effects of the virus.
The significant increase in the use of stem cell treatment was as a result of the UAE Government’s decision to make the treatment – called UAECell19 – available free of charge to all moderate-to-high risk COVID-19 patients in the country.
A team of doctors and researchers at ADSCC, led by Dr Yendry Ventura, announced in May they had developed a new treatment for COVID-19 patients. Following an initial trial, researchers were able to conclude that UAECell19 reduced the duration of hospitalisation from 22 days to just six, when compared to patients who received standard treatment.
Further analysis revealed that patients treated with the stem cells were 3.1 times more likely to recover in less than seven days than those treated with standard therapy, and 67% of the patients who received the stem cells treatment owed this recovery to the new treatment.
ADSCC said researchers are at various stages of several investigatory efforts to establish effectiveness (Phase 3 trial), optimal efficacy of dosage, and efficacy to treat other respiratory diseases such asthma, COPD, and cystic fibrosis.